Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADC189 in children with influenza
NCT06507813Phase 3Completed
- Sponsor
- Jiaxing AnDiCon Biotech
- Start
- Aug 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of deunoxavir marboxil in influenza, sponsored by Jiaxing AnDiCon Biotech. Started Aug 2024; status: completed.
02
Drugs
deunoxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT06507813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06507813.